Ondansetron Hydrochloride recalls
Ondansetron Hydrochloride products have been recalled 2 times, most recently on 13 Dec 2023. The recalling company is usually Mckesson Medical-Surgical Inc. Corporate Office.
Total recalls2since 2022
Last 12 months0reported
Class I00% of total
Ongoing0latest 13 Dec 2023
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why ondansetron hydrochloride is recalled
Companies
Product types
By year
All ondansetron hydrochloride recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Ondansetron Injection, USP, 4 mg/ (2 mg/mL) per vial recalledOndansetron Hydrochloride | Baxter Healthcare | Other | Nationwide |
| Drug | CLASS II | Ondansetron HCL, Tab 8 mg filmcoated recalledOndansetron Hydrochloride | Mckesson Medical-Surgical Inc. Corporate Office | Manufacturing (CGMP) Deviations | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.